Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens
- PMID: 10025864
- DOI: 10.1016/s0190-9622(99)70481-0
Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens
Abstract
The clinical and immunopathologic features of children with acquired subepidermal blistering disorders show considerable overlap, and their classification frequently requires characterization of the targeted antigens. A 8-month-old boy developed a generalized subepidermal blistering disorder with striking palmoplantar involvement. The patient's serum contained antibodies reacting against the epidermal side of 1 M sodium chloride separated normal human skin. Immunoblotting analysis demonstrated circulating IgG autoantibodies that reacted against a eukaryotic recombinant form of human bullous pemphigoid antigen 180 (BP180). In addition, the patient had circulating IgG autoantibodies that bound a protein of 120 kDa in skin basement membrane zone extracts, that might correspond to the linear IgA bullous disease (LABD) antigen. This study illustrates that a child with clinical and immunopathologic features considered characteristic of childhood bullous pemphigoid (BP) had circulating IgG antibodies that bound to an eukaryotic recombinant form of human BP180, and hence, fulfilled the diagnostic criteria of BP. Review of the literature disclosed only 10 cases of childhood BP, that were characterized on the basis of the targeted antigens. The concomitant presence of circulating IgG autoantibodies against BP180 and a 120 kDa protein may signify either coexistence of autoantibodies with distinct specificities or reflect antigenic cross-reactivity between BP180 and the 120/97 LABD antigen.
Similar articles
-
Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.Vet Pathol. 1995 Jul;32(4):387-93. doi: 10.1177/030098589503200407. Vet Pathol. 1995. PMID: 7483213
-
Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.Br J Dermatol. 2006 Jan;154(1):90-8. doi: 10.1111/j.1365-2133.2005.06998.x. Br J Dermatol. 2006. PMID: 16403100
-
Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.Arch Dermatol. 2000 Apr;136(4):527-32. doi: 10.1001/archderm.136.4.527. Arch Dermatol. 2000. PMID: 10768652 Review.
-
Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.Br J Dermatol. 2001 Mar;144(3):540-5. doi: 10.1046/j.1365-2133.2001.04080.x. Br J Dermatol. 2001. PMID: 11260011
-
[New aspects on the pathogenesis of bullous pemphigoid].Hautarzt. 2000 Sep;51(9):637-45. doi: 10.1007/s001050051188. Hautarzt. 2000. PMID: 11057389 Review. German.
Cited by
-
Molecular diagnosis in autoimmune skin blistering conditions.Curr Mol Med. 2014 Jan;14(1):69-95. doi: 10.2174/15665240113136660079. Curr Mol Med. 2014. PMID: 24160488 Free PMC article. Review.
-
Bullous Diseases in Children: A Review of Clinical Features and Treatment Options.Paediatr Drugs. 2019 Oct;21(5):345-356. doi: 10.1007/s40272-019-00349-3. Paediatr Drugs. 2019. PMID: 31506891 Review.
-
Bullous pemphigoid in infants: characteristics, diagnosis and treatment.Orphanet J Rare Dis. 2014 Dec 10;9:185. doi: 10.1186/s13023-014-0185-6. Orphanet J Rare Dis. 2014. PMID: 25491396 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous